Expert Advice 24 Jan 2022 Transitioning from Academia to Chief Scientific Officer in the Biotech Industry Academics with a drive to turn their research into commercial products often end up in the position of Chief Scientific Officer at a biotech company. Kees Melief shares his own personal experience transitioning from academia to industry. After his retirement as an academic researcher at Leiden University, Cornelis ‘Kees’ Melief founded and became the Chief […] January 24, 2022 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jan 2022 Two Gene Therapy Players Launch IPOs on Stormy Stock Market After a drought of more than a year, the European gene therapy sector saw initial public offerings from Genenta Science and Genflow Biosciences. The firms aim to shine as biotech stocks elsewhere perform poorly. Until recently, European gene therapy companies were going through a dry spell in terms of launching initial public offerings (IPO). The […] January 21, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jan 2022 Engitix Builds Liver Disease Pipeline with Series A and Drug Collaboration With the close of its Series A round at €48M ($54M), the tissue models company Engitix has shifted its business from providing drug discovery services to developing its own treatment pipeline for liver diseases. When Engitix was spun out of University College London in 2016, the startup primarily aimed to provide tissue models to pharmaceutical […] January 19, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Jan 2022 Glycans Hit the Sweet Spot in Diagnostics The surface of our cells are covered in sugar molecules called glycans. The field of glycomics leverages their enormous diversity to develop better and more precise diagnostics. More commonly known as sugars or carbohydrates, glycans are involved in a range of crucial biological roles, including maintaining tissue elasticity, tackling pathogens, and modulating the immune system. […] January 19, 2022 - 5 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2022 Ori Biotech Bags €88M Investment to Automate Cell Therapy Manufacture The UK company Ori Biotech has raised €88M ($100M) in Series B cash to ease the cell therapy manufacturing bottleneck using automation and standardized data collection. The round was 40% oversubscribed and led by the US investment firm Novalis LifeSciences. The Chinese investor Puhua Capital and Chimera Abu Dhabi joined the existing syndicate, which includes […] January 18, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 18 Jan 2022 Biomining: Turning Waste into Gold with Microbes High-value metals make the modern world go round, but the way we extract and dispose of them is far from sustainable. Biomining could be an elegant and lucrative alternative. From the gold and silver in consumer electronics to the rare earth elements needed to power renewable energy technologies, metals underpin the transition to a high-tech, […] January 18, 2022 - 7 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
Sponsored by Cytiva 18 Jan 2022 How to Make Cell Culture Expansion Easy Cell culture expansion for biotherapeutic development has traditionally involved a series of time-consuming, labor-intensive batch cultures that are susceptible to contamination. Cell culture expansion using a perfusion process promises easy scalability, ensures high productivity gains, and saves time and costs during large-scale biomanufacturing. Cell culture is a crucial tool in the biotech sector. Applications range […] January 18, 2022 - 7 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email
Inside Labiotech 18 Jan 2022 Labiotech.eu Is Being Acquired by Inova We’ve got some amazing news we’re dying to tell you about, and now we can finally let the cat out of the bag: Inova, the leading biopharma partnering platform has acquired Labiotech! Ever heard of Inova? Inova is a cloud-based solution helping life science companies locate and manage their partnering opportunities more efficiently. The company […] January 18, 2022 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jan 2022 Swiss Startup Signs on with Novo Nordisk to Discover Obesity Treatments The Swiss startup EraCal Therapeutics has signed a research partnership with the Danish pharmaceutical giant Novo Nordisk to search for treatments controlling food intake and other factors contributing to obesity. Under the joint project, EraCal and Novo Nordisk will research targets for obesity treatments by identifying molecules that can control appetite and improve metabolic health. […] January 17, 2022 - 3 minutesmins - By Dan Samorodnitsky Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jan 2022 Europe Trailed US Despite Record Gene and Cell Therapy Funding in 2021 Cell and gene therapy developers globally raised an all-time annual record in 2021. However, European firms missed out on the funding growth. Companies around the world developing cell and gene therapies raised €20.1B ($23.1B) over 2021, said the advanced therapy advocacy organization the Alliance for Regenerative Medicine (ARM) in a briefing this week. This bumper […] January 14, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jan 2022 Biotech Startup Incubators Prepare to Cash in on Record VC Funding Venture capital funding broke records in the biotech industry in 2021. Leading startup incubators from across Europe share their plans to make the most of this trend in 2022, with expectations for big returns and expansion in the works. In spite of financial volatility resulting from the Covid-19 pandemic, the year 2021 broke records for […] January 13, 2022 - 7 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2022 Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia As big pharma companies flock to drug discovery collaborations with artificial intelligence (AI) firms, the French giant Sanofi has sealed a €4.6B deal with the UK AI player Exscientia to develop oncology and immunology treatments. According to the deal’s terms, the partners will develop up to 15 small molecule drugs to treat cancer and immunological […] January 11, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email